Literature DB >> 16381006

Tumour-cell apoptosis after cisplatin treatment is not telomere dependent.

Jessie C Jeyapalan1, Gabriele Saretzki, Alan Leake, Michael J Tilby, Thomas von Zglinicki.   

Abstract

Cisplatin is a major chemotherapeutic agent, especially for the treatment of neuroblastoma. Telomeres with their sequence (TTAGGG)n are probable targets for cisplatin intrastrand cross-linking, but the role of telomeres in mediating cisplatin cytotoxicity is not clear. After exposure to cisplatin as single dose or continuous treatment, we found no loss of telomeres in either SHSY5Y neuroblastoma cells (telomere length, approximately 4 kbp), HeLa 229 cells (telomere length, 20 kbp) or in the acute lymphoblastic T cell line 1301 (telomere length, approximately 80 kbp). There was no induction of telomeric single strand breaks, telomeric overhangs were not degraded and telomerase activity was down-regulated only after massive onset of apoptosis. In contrast, cisplatin induced a delayed formation of DNA strand breaks and induced DNA damage foci containing gamma-H2A.X at nontelomeric sites. Interstitial DNA damage appears to be more important than telomere loss or telomeric damage as inducer of the signal pathway towards apoptosis and/or growth arrest in cisplatin-treated tumour cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16381006     DOI: 10.1002/ijc.21675

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Improved procedure for the measurement of telomere length in whole cells by PNA probe and flow cytometry.

Authors:  M Carbonari; D Mancaniello; M Cibati; A Catizone; M Fiorilli
Journal:  Cell Prolif       Date:  2010-12       Impact factor: 6.831

2.  Correlation between terminal restriction fragments and flow-FISH measures in samples over wide range telomere lengths.

Authors:  M Carbonari; T Tedesco; M Fiorilli
Journal:  Cell Prolif       Date:  2014-02       Impact factor: 6.831

3.  Platination of telomeric DNA by cisplatin disrupts recognition by TRF2 and TRF1.

Authors:  Isabelle Ourliac-Garnier; Anaïs Poulet; Razan Charif; Simon Amiard; Frédérique Magdinier; Keyvan Rezaï; Eric Gilson; Marie-Josèphe Giraud-Panis; Sophie Bombard
Journal:  J Biol Inorg Chem       Date:  2010-02-27       Impact factor: 3.358

4.  IP(3) receptor antagonist, 2-APB, attenuates cisplatin induced Ca2+-influx in HeLa-S3 cells and prevents activation of calpain and induction of apoptosis.

Authors:  F Splettstoesser; A-M Florea; D Büsselberg
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

5.  Modification of cyclic NGR tumor neovasculature-homing motif sequence to human plasminogen kringle 5 improves inhibition of tumor growth.

Authors:  Weiwei Jiang; Guanghui Jin; Dingyuan Ma; Feng Wang; Tong Fu; Xiao Chen; Xiwen Chen; Kunzhi Jia; Faiz M M T Marikar; Zichun Hua
Journal:  PLoS One       Date:  2012-05-10       Impact factor: 3.240

6.  Platinum Complexes Can Bind to Telomeres by Coordination.

Authors:  Lina Saker; Samar Ali; Caroline Masserot; Guillaume Kellermann; Joel Poupon; Marie-Paule Teulade-Fichou; Evelyne Ségal-Bendirdjian; Sophie Bombard
Journal:  Int J Mol Sci       Date:  2018-07-03       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.